-
公开(公告)号:US07517525B2
公开(公告)日:2009-04-14
申请号:US10190548
申请日:2002-07-09
IPC分类号: A61K39/395
CPC分类号: C07K16/18 , A61K38/39 , A61K2039/505 , C07K16/2839 , C07K16/2842
摘要: The present invention features methods and compositions for inhibiting amyloidogenic protein toxicity, inhibiting formation of an amyloidogenic protein deposit and/or treating amyloidogenic diseases by administering a pharmaceutically effective amount of one or more agents that bind an integrin or an integrin subunit.
摘要翻译: 本发明的特征在于通过施用药物有效量的一种或多种结合整联蛋白或整联蛋白亚基的试剂来抑制淀粉样蛋白形成蛋白毒性,抑制淀粉样蛋白形成蛋白沉积物的形成和/或治疗淀粉样变性疾病的方法和组合物。
-
公开(公告)号:US07901683B2
公开(公告)日:2011-03-08
申请号:US12336340
申请日:2008-12-16
IPC分类号: A61K39/395
CPC分类号: C07K16/18 , A61K38/39 , A61K2039/505 , C07K16/2839 , C07K16/2842
摘要: The present invention features methods and compositions for inhibiting amyloidogenic protein toxicity, inhibiting formation of an amyloidogenic protein deposit and/or treating amyloidogenic diseases by administering a pharmaceutically effective amount of one or more agents that bind an integrin or an integrin subunit.
摘要翻译: 本发明的特征在于通过施用药物有效量的一种或多种结合整联蛋白或整联蛋白亚基的试剂来抑制淀粉样蛋白形成蛋白毒性,抑制淀粉样蛋白形成蛋白沉积物的形成和/或治疗淀粉样变性疾病的方法和组合物。
-
3.
公开(公告)号:US07674597B2
公开(公告)日:2010-03-09
申请号:US11193353
申请日:2005-08-01
IPC分类号: G01N33/567 , G01N33/53
CPC分类号: C07K14/4711 , C07K14/47 , G01N33/5058 , G01N2800/2821
摘要: The invention provides a novel human protein, FISH adaptor protein, involved in amyloid β-protein-mediated cell death. Also provided are methods for modulating amyloid β-protein-mediated cell death using agents that interfere with the activity of FISH adaptor protein.
摘要翻译: 本发明提供了一种涉及淀粉样蛋白和蛋白质介导的细胞死亡的新型人蛋白质FISH衔接蛋白。 还提供了使用干扰FISH衔接蛋白的活性的试剂调节淀粉样蛋白和蛋白质介导的细胞死亡的方法。
-
公开(公告)号:US09358273B2
公开(公告)日:2016-06-07
申请号:US13519949
申请日:2011-01-06
IPC分类号: A61K38/39
CPC分类号: A61K38/39
摘要: The application reports that perlecan domain V (DV) or the LG3 domain thereof reduces deposition and toxicity of Aβ peptide, the major component of plaques in Alzheimer's disease. Methods of using DV, LG3 and related molecules in treatment of amyloidogenic diseases, particularly Alzheimer's disease, are provided.
摘要翻译: 该应用报告说,perlecan域V(DV)或其LG3结构域减少了A&bgr的沉积和毒性; 肽,阿尔茨海默病斑块的主要成分。 提供了使用DV,LG3和相关分子治疗淀粉样变性疾病,特别是阿尔茨海默氏病的方法。
-
5.
公开(公告)号:US20060159674A1
公开(公告)日:2006-07-20
申请号:US11193353
申请日:2005-08-01
IPC分类号: A61K39/395 , A61K38/17
CPC分类号: C07K14/4711 , C07K14/47 , G01N33/5058 , G01N2800/2821
摘要: The invention provides a novel human protein, FISH adaptor protein, involved in amyloid β-protein-mediated cell death. Also provided are methods for modulating amyloid β-protein-mediated cell death using agents that interfere with the activity of FISH adaptor protein.
摘要翻译: 本发明提供了涉及淀粉样蛋白β-蛋白介导的细胞死亡的新型人蛋白质FISH衔接蛋白。 还提供了使用干扰FISH衔接蛋白的活性的试剂调节淀粉样蛋白β-蛋白介导的细胞死亡的方法。
-
公开(公告)号:US20080193444A1
公开(公告)日:2008-08-14
申请号:US11723745
申请日:2007-03-21
申请人: Sarah Wright , Irene Griswold-Prenner , Qinwen Wang , Igor Klyubin , Michael Rowan , Roger Anwyl
发明人: Sarah Wright , Irene Griswold-Prenner , Qinwen Wang , Igor Klyubin , Michael Rowan , Roger Anwyl
IPC分类号: A61K39/395 , A61P25/28 , A61K38/02 , A61K31/4178 , A61P25/00 , A61K48/00 , G01N33/53 , G01N33/566 , A61P3/10 , A61K38/17 , A61K38/39 , A61P25/16
CPC分类号: C07K16/2842 , A61K31/4178 , A61K38/39 , A61K2039/505 , C07K16/18 , C07K16/2839 , C07K2317/76
摘要: Methods and compositions for suppressing amyloid-mediated inhibition of long-term potentiation (LTP) are provided.
摘要翻译: 提供了抑制淀粉样蛋白介导的长期增强抑制(LTP)的方法和组合物。
-
公开(公告)号:US20130036481A1
公开(公告)日:2013-02-07
申请号:US13519949
申请日:2011-01-06
IPC分类号: A61K38/17 , A61K38/08 , A61K39/395 , A61K49/00 , A61P25/16 , A61P25/28 , C12N5/071 , G01N33/566 , A61K38/10 , A61P3/10
CPC分类号: A61K38/39
摘要: The application reports that perlecan domain V (DV) or the LG3 domain thereof reduces deposition and toxicity of Aβ peptide, the major component of plaques in Alzheimer's disease. Methods of using DV, LG3 and related molecules in treatment of amyloidogenic diseases, particularly Alzheimer's disease, are provided.
摘要翻译: 该应用报告说,perlecan域V(DV)或其LG3结构域减少了A&bgr的沉积和毒性; 肽,阿尔茨海默病斑块的主要成分。 提供了使用DV,LG3和相关分子治疗淀粉样变性疾病,特别是阿尔茨海默氏病的方法。
-
公开(公告)号:US07829087B2
公开(公告)日:2010-11-09
申请号:US11723745
申请日:2007-03-21
IPC分类号: A61K39/395
CPC分类号: C07K16/2842 , A61K31/4178 , A61K38/39 , A61K2039/505 , C07K16/18 , C07K16/2839 , C07K2317/76
摘要: Methods and compositions for suppressing amyloid-mediated inhibition of long-term potentiation (LTP) are provided.
摘要翻译: 提供了抑制淀粉样蛋白介导的长期增强抑制(LTP)的方法和组合物。
-
-
-
-
-
-
-